SURGICAL TREATMENT OF UPPER GASTROINTESTINAL BLEEDING: A SIMPLIFIED REVIEW
##semicolon##
Key words: Upper gastrointestinal bleeding, esophageal varices, peptic ulcer disease, medication, surgery, blood loss##article.abstract##
Abstract: Upper gastrointestinal bleeding (UGIB) is a medical emergency that can be life-threatening, especially in older patients and those with other health problems. While most cases can be managed with medications and endoscopy, around 10-15% require surgery when other treatments don’t work. This review covers when and why surgery is needed for UGIB, the types of surgical procedures used, comparisons with other non-surgical treatments, and newer techniques that are being developed. The goal is to provide a clear understanding of the role of surgery in treating UGIB based on the latest evidence.
##submission.citations##
1. Oakland K.Changing epidemiology of upper gastrointestinal hemorrhage in the 21st century. Clin Gastroenterol Hepatol. 2022;20(6):e1065-e1080.
2. Wuerth BA, Rockey DC. Changing epidemiology of upper GI hemorrhage in the US. JAMA Intern Med. 2018;178(3):421-422.
3. Swain CP. The history of endoscopic hemostasis. Gastrointest Endosc Clin N Am. 2015;25(3):xiii-xviii.
4. Lau JYW. Timing of endoscopy for acute upper GI bleeding. N Engl J Med. 2020;382(14):1299-1308.
5. Khamaysi I. Epinephrine plus second modality vs epinephrine alone: meta-analysis. Gastrointest Endosc. 2021;93(4):AB123.
6. Gralnek IM. Ethanol injection risks in gastric ulcers. Endoscopy. 2019;51(8):734-741.
7. Barkun AN. Cost-effectiveness of fibrin glue. Am J Gastroenterol. 2020;115(3):412-420.
8. Jensen DM. BICAP vs heater probe: multicenter RCT. Clin Gastroenterol Hepatol. 2018;16(5):679-687.
9. Suzuki N. APC depth penetration study. Endosc Int Open. 2022;10(3):E215-E221.
10. Park CH. Dieulafoy lesion outcomes. Gut Liver. 2021;15(2):256-263.
11. Sung JJY. Clip therapy for Forrest Ia. Lancet Gastroenterol Hepatol. 2019;4(10):790-798.
12. Schmidt A. OTSC registry data. Endoscopy. 2020;52(9):769-776.
13. Chen YI. TC-325 cost-effectiveness. Gastrointest Endosc. 2023;97(1):134-142.
14. de Franchis R. EVL vs sclerotherapy: Baveno VII. J Hepatol. 2022;77(1):179-190.
REFERENCES
1. Barkun, A. N., Bardou, M., Kuipers, E. J., Sung, J., Hunt, R. H., Martel, M., ... & International Consensus Upper Gastrointestinal Bleeding Conference Group*. (2010). International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Annals of internal medicine, 152(2), 101-113.
2. [ ] Cook, D. J., Fuller, H. D., Guyatt, G. H., Marshall, J. C., Leasa, D., Hall, R., ... & Willan, A. (1994). Risk factors for gastrointestinal bleeding in critically ill patients. New England journal of medicine, 330(6), 377-381.
3. [ ] Gutthann, S. P., GarcíaRodríguez, L. A., & Raiford, D. S. (1997). Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology, 8(1), 18-24.
4. [ ] Tielleman, T., Bujanda, D., & Cryer, B. (2015). Epidemiology and risk factors for upper gastrointestinal bleeding. Gastrointestinal Endoscopy Clinics, 25(3), 415-428.
5. [ ] Johnsen, S. P., Sørensen, H. T., Mellemkjœr, L., Blot, W. J., Nielsen, G. L., McLaughlin, J. K., & Olsen, J. H. (2001). Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants. Thrombosis and haemostasis, 86(08), 563-568.
6. [ ] Cerini, F., Gonzalez, J. M., Torres, F., Puente, Á., Casas, M., Vinaixa, C., ... & Garcia‐Pagán, J. C. (2015). Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study. Hepatology, 62(2), 575-583.
7. [ ] Lee, M. W., & Katz, P. O. (2021). Nonsteroidal antiinflammatory drugs, anticoagulation, and upper gastrointestinal bleeding. Clinics in Geriatric Medicine, 37(1), 31-42.
8. [ ] Ibanez, L., Vidal, X., Vendrell, L., Moretti, U., Laporte, J. R., & SPANISH–ITALIAN COLLABORATIVE GROUP FOR THE EPIDEMIOLOGY OF GASTROINTESTINAL BLEEDING. (2006). Upper gastrointestinal bleeding associated with antiplatelet drugs. Alimentary pharmacology & therapeutics, 23(2), 235-242.
9. [ ] Lanas, A., & Scheiman, J. (2007). Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Current medical research and opinion, 23(1), 163-173.
10. [ ] Fletcher, E. H., Johnston, D. E., Fisher, C. R., Koerner, R. J., Newton, J. L., & Gray, C. S. (2010). Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin. Alimentary pharmacology & therapeutics, 32(7), 831-839.
11. [ ] Liberopoulos, E. N., Elisaf, M. S., Tselepis, A. D., Archimandritis, A., Kiskinis, D., Cokkinos, D., & Mikhailidis, D. P. (2006). Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?. Platelets, 17(1), 1-6.
12. [ ] de Abajo, F. J., Rodríguez, L. A. G., & Montero, D. (1999). Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. Bmj, 319(7217), 1106-1109.
13. [ ] Anglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I. (2014). Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Official journal of the American College of Gastroenterology| ACG, 109(6), 811-819.
14. [ ] Rahman, A. A., He, N., Rej, S., Platt, R. W., & Renoux, C. (2022). Concomitant use of selective serotonin reuptake inhibitors and oral anticoagulants and risk of major bleeding: a systematic review and meta-analysis. Thrombosis and Haemostasis.
15. [ ] Alam, S. M., Qasswal, M., Ahsan, M. J., Walters, R. W., & Chandra, S. (2022). Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis. Scientific Reports, 12(1), 14452.